These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31760649)

  • 21. Mitochondrial Dynamics in Physiology and Pathology of Myelinated Axons.
    Sui Y; Nguyen HB; Thai TQ; Ikenaka K; Ohno N
    Adv Exp Med Biol; 2019; 1190():145-163. PubMed ID: 31760643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelin loss does not lead to axonal degeneration in a long-lived model of chronic demyelination.
    Smith CM; Cooksey E; Duncan ID
    J Neurosci; 2013 Feb; 33(6):2718-27. PubMed ID: 23392698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropathology in multiple sclerosis: new concepts.
    Lassmann H
    Mult Scler; 1998 Jun; 4(3):93-8. PubMed ID: 9762654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review: Mitochondria and disease progression in multiple sclerosis.
    Mahad D; Lassmann H; Turnbull D
    Neuropathol Appl Neurobiol; 2008 Dec; 34(6):577-89. PubMed ID: 19076696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental strategies to promote central nervous system remyelination in multiple sclerosis: insights gained from the Theiler's virus model system.
    Miller DJ; Asakura K; Rodriguez M
    J Neurosci Res; 1995 Jun; 41(3):291-6. PubMed ID: 7563222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.
    Bitsch A; Schuchardt J; Bunkowski S; Kuhlmann T; Brück W
    Brain; 2000 Jun; 123 ( Pt 6)():1174-83. PubMed ID: 10825356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental Autoimmune Encephalomyelitis (EAE)-Induced Elevated Expression of the E1 Isoform of Methyl CpG Binding Protein 2 (MeCP2E1): Implications in Multiple Sclerosis (MS)-Induced Neurological Disability and Associated Myelin Damage.
    Khorshid Ahmad T; Zhou T; AlTaweel K; Cortes C; Lillico R; Lakowski TM; Gozda K; Namaka MP
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28604632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients.
    Dutta R; Chang A; Doud MK; Kidd GJ; Ribaudo MV; Young EA; Fox RJ; Staugaitis SM; Trapp BD
    Ann Neurol; 2011 Mar; 69(3):445-54. PubMed ID: 21446020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preservation of neurologic function during inflammatory demyelination correlates with axon sparing in a mouse model of multiple sclerosis.
    Ure DR; Rodriguez M
    Neuroscience; 2002; 111(2):399-411. PubMed ID: 11983325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
    Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
    J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central nervous system demyelination and remyelination in multiple sclerosis and viral models of disease.
    Rodriguez M
    J Neuroimmunol; 1992 Oct; 40(2-3):255-63. PubMed ID: 1430155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demyelination and axonal degeneration in Lewis rat experimental allergic neuritis depend on the myelin dosage.
    Hahn AF; Feasby TE; Steele A; Lovgren DS; Berry J
    Lab Invest; 1988 Jul; 59(1):115-25. PubMed ID: 3260639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sclerosis - candidate mechanisms underlying CNS atrophy.
    Siffrin V; Vogt J; Radbruch H; Nitsch R; Zipp F
    Trends Neurosci; 2010 Apr; 33(4):202-10. PubMed ID: 20153532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remyelinating strategies in multiple sclerosis.
    Luessi F; Kuhlmann T; Zipp F
    Expert Rev Neurother; 2014 Nov; 14(11):1315-34. PubMed ID: 25331418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
    Leitner H
    Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of tissue injury in MS lesions.
    Trapp BD; Bö L; Mörk S; Chang A
    J Neuroimmunol; 1999 Jul; 98(1):49-56. PubMed ID: 10426362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance is futile: antineuronal autoimmunity in multiple sclerosis.
    Huizinga R; Linington C; Amor S
    Trends Immunol; 2008 Feb; 29(2):54-60. PubMed ID: 18182323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astrocytes--friends or foes in multiple sclerosis?
    Williams A; Piaton G; Lubetzki C
    Glia; 2007 Oct; 55(13):1300-12. PubMed ID: 17626262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple sclerosis: an immune or neurodegenerative disorder?
    Trapp BD; Nave KA
    Annu Rev Neurosci; 2008; 31():247-69. PubMed ID: 18558855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.